Larimar Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Larimar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Larimar Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Larimar Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $902k | 119k | 7.59 |
| 2023-12-31 | $275k | 61k | 4.55 |
| 2023-09-30 | $110k | 28k | 3.95 |
| 2023-06-30 | $194k | 62k | 3.13 |
| 2023-03-31 | $3.0M | 672k | 4.53 |
| 2022-12-31 | $220k | 45k | 4.90 |
| 2022-06-30 | $2.8k | 2.0k | 1.39 |
| 2022-03-31 | $9.0k | 2.1k | 4.28 |
| 2021-12-31 | $17k | 1.6k | 10.77 |
| 2021-03-31 | $0 | 12 | 0.00 |
| 2020-12-31 | $0 | 12 | 0.00 |